Metabolic flexibility and reverse remodelling of the failing human heart
Green PG. et al, (2025), European Heart Journal
Inflammatory cardiovascular events and coronary artery disease – Authors' reply
Chan K. et al, (2025), The Lancet, 405, 545 - 546
Multiparametric cardiovascular magnetic resonance evaluation of myocardial perfusion, oxygenation, and energetics in hypertrophic cardiomyopathy following cardiac myosin inhibitor therapy
Finnigan LEM. et al, (2025), European Heart Journal - Cardiovascular Imaging, 26, 378 - 378
Myocardial disarray and fibrosis across hypertrophic cardiomyopathy stages associate with ECG markers of arrhythmic risk.
Ashkir Z. et al, (2025), European heart journal. Cardiovascular Imaging, 26, 218 - 228
Relationship between left ventricular shape and cardiovascular risk factors: comparison between the Multi-Ethnic Study of Atherosclerosis and UK Biobank.
Suinesiaputra A. et al, (2025), Heart (British Cardiac Society)
1H and 31P MR Spectroscopy to Assess Muscle Mitochondrial Dysfunction in Long COVID
Finnigan LEM. et al, (2024), Radiology, 313
1H and 31P MR Spectroscopy to Assess Muscle Mitochondrial Dysfunction in Long COVID
Finnigan LEM. et al, (2024), Radiology, 313
Etiology and Phenotypes of Cardiomyopathy in Southern Africa: The IMHOTEP Multicenter Pilot Study.
Kraus SM. et al, (2024), JACC. Advances, 3
Myocardial ischaemia following COVID-19: a cardiovascular magnetic resonance study.
Arnold JR. et al, (2024), The international journal of cardiovascular imaging
Protein Biomarkers of Adverse Clinical Features and Events in Sarcomeric Hypertrophic Cardiomyopathy.
Tahir UA. et al, (2024), Circulation. Heart failure, 17
Quantitative susceptibility mapping at 7 T in COVID-19: brainstem effects and outcome associations.
Rua C. et al, (2024), Brain : a journal of neurology, 147, 4121 - 4130
Exploring cardiovascular involvement in IgG4-related disease: a case series approach with cardiovascular magnetic resonance
Henry JA. et al, (2024), Heart
Cardiac function and energetics in mice with combined genetic augmentation of creatine and creatine kinase activity
Zervou S. et al, (2024), Journal of Molecular and Cellular Cardiology, 196, 105 - 114
Clinical Significance of Myocardial Injury in Patients Hospitalized for COVID-19: A Prospective, Multicenter, Cohort Study.
Shiwani H. et al, (2024), JACC. Cardiovascular imaging, 17, 1320 - 1331
Diagnostic utility of electrocardiogram for screening of cardiac injury on cardiac magnetic resonance in post-hospitalised COVID-19 patients: a prospective multicenter study
Samat AHA. et al, (2024), International Journal of Cardiology, 415, 132415 - 132415
Hyperpolarized 13C and 31P MRS detects differences in cardiac energetics, metabolism, and function in obesity, and responses following treatment
Lewis AJM. et al, (2024), NMR in Biomedicine, 37
Considerations for drug trials in hypertrophic cardiomyopathy.
Farrant JP. et al, (2024), ESC heart failure
Cost-effectiveness of a novel AI technology to quantify coronary inflammation and cardiovascular risk in patients undergoing routine coronary computed tomography angiography
Tsiachristas A. et al, (2024), European Heart Journal - Quality of Care and Clinical Outcomes
1-year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort study.
Leavy OC. et al, (2024), ERJ open research, 10, 474 - 2024
Automatic Plane Pose Estimation for Cardiac Left Ventricle Coverage Estimation via Deep Adversarial Regression Network
Zhang L. et al, (2024), IEEE Transactions on Artificial Intelligence, 5, 4738 - 4752